Literature DB >> 12840222

The nuclear pregnane X receptor regulates xenobiotic detoxification.

Steven A Kliewer1.   

Abstract

The pregnane X receptor (PXR), which is a member of the nuclear receptor family of ligand-activated transcription factors, is an integral component of the body's defense mechanism against toxic xenobiotics. PXR is activated by a broad spectrum of lipophilic xenobiotics including prescription drugs, herbs, pesticides, endocrine disruptors and other environmental contaminants. The promiscuous ligand-binding properties of PXR are facilitated by the large volume and smooth shape of its ligand-binding pocket. PXR binds to DNA as a heterodimer with the 9-cis retinoic acid receptor (RXR) and regulates a large number of genes involved in the detoxification and excretion of toxic substances. Although PXR evolved to protect the body, its activation by various prescription drugs and herbs such as St. John's wort represents the molecular basis for an important class of drug-drug interactions. Assays that detect PXR activation can now be used to predict and prevent these drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12840222     DOI: 10.1093/jn/133.7.2444S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  40 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  The role of nuclear receptors in the kidney in obesity and metabolic syndrome.

Authors:  Claudia Tovar-Palacio; Nimbe Torres; Andrea Diaz-Villaseñor; Armando R Tovar
Journal:  Genes Nutr       Date:  2012-04-25       Impact factor: 5.523

Review 3.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

4.  A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet.

Authors:  Georges de Sousa; Ahmad Nawaz; Jean-Pierre Cravedi; Roger Rahmani
Journal:  Toxicol Sci       Date:  2014-07-15       Impact factor: 4.849

5.  Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Authors:  Caitlin Lynch; Yongmei Pan; Linhao Li; Stephen S Ferguson; Menghang Xia; Peter W Swaan; Hongbing Wang
Journal:  Pharm Res       Date:  2012-10-23       Impact factor: 4.200

6.  Human PXR forms a tryptophan zipper-mediated homodimer.

Authors:  Schroeder M Noble; Virginia E Carnahan; Linda B Moore; Tom Luntz; Hongbing Wang; Olivia R Ittoop; Julie B Stimmel; Paula R Davis-Searles; Ryan E Watkins; G Bruce Wisely; Ed LeCluyse; Ashutosh Tripathy; Donald P McDonnell; Matthew R Redinbo
Journal:  Biochemistry       Date:  2006-07-18       Impact factor: 3.162

7.  Adverse effects of vitamin E by induction of drug metabolism.

Authors:  Regina Brigelius-Flohé
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

8.  Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Yuan Zhang; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-26       Impact factor: 4.219

9.  Structural basis of human pregnane X receptor activation by the hops constituent colupulone.

Authors:  Denise G Teotico; Jason J Bischof; Li Peng; Steven A Kliewer; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

Review 10.  PXR antagonists and implication in drug metabolism.

Authors:  Sridhar Mani; Wei Dou; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.